Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03546582
Brief Title: SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (KEYSTROKE)

First Submitted : May 23, 2018
First Submitted that Met QC Criteria : May 23, 2018
First Posted : June 6, 2018

Last Update Submitted that Met QC Criteria : November 5, 2021
Last Update Posted : November 9, 2021